Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

Targeted therapies require information on specific defective signaling pathways or mutations. Advances in genomic technologies and cell biology have led to identification of new therapeutic targets associated with signal-transduction pathways. Survival times of patients with colorectal cancer (CRC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Seow, Heng Fong, Yip, Wai Kien, Fifis, Theodora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821380/
https://www.ncbi.nlm.nih.gov/pubmed/27099521
http://dx.doi.org/10.2147/OTT.S95101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821380/
https://www.ncbi.nlm.nih.gov/pubmed/27099521
http://dx.doi.org/10.2147/OTT.S95101

Ejemplares similares